Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council

Advisors, including human performance expert Jamie Wheal and mental health advocate Ben Nemtin, join Numinus to help guide and inform company leadership   VANCOUVER, BC, Oct. 14, 2020 /PRNewswire/ – Recognized and respected leaders from technology, pharmacology, and health have joined Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI) as members of the Company’s General Advisory Council. DrawingContinue reading “Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council”

Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone

VANCOUVER, BC, Oct. 6, 2020 /CNW/ – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (Frankfurt: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, is pleased to announce that further to the news release dated March 30th, 2020, its 100% owned subsidiary, Venom ExtractsContinue reading “Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone”

PSYC Revamps Their Online Presence with a Relaunch of Corporate Website

— Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company has completed the redevelopment and relaunch of its corporate website; www.globaltracsolutions.com with the intent of showcasing PSYC’s emergence as a digital media leader within the expanding medicinal psychedelic industry. Earlier this year, the Company began the process ofContinue reading “PSYC Revamps Their Online Presence with a Relaunch of Corporate Website”

Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19

 — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company’s expanded access protocol (“EAP”) for compassionate use of Bucillamine in the treatment of COVID-19 received approval fromContinue reading “Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19”

Numinus Announces Closing of Oversubscribed $4.6 Million Offering

– Numinus Wellness Inc. (“Numinus” or the “Company“) (TSXV: NUMI), is pleased to announce that it has closed its previously announced short form prospectus offering, on a best efforts basis, including the exercise of the agent’s option in its entirety in the form of units of the Company (each, a “Unit“). A total of 18,400,000 UnitsContinue reading “Numinus Announces Closing of Oversubscribed $4.6 Million Offering”

Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company’s Phase 3 clinical trial protocol to evaluate the safety and efficacy of Bucillamine in patients with mild-moderateContinue reading “Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19”

Hollister Biosciences Inc. Reports Second Quarter 2020 Results

Multi-state operator and diversified cannabis branding company generates record quarterly revenue and delivers profitable second quarter – Hollister Biosciences Inc. (CSE: HOLL), (OTC: HSTRF), (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, announces financial results for the second quarter 2020Continue reading “Hollister Biosciences Inc. Reports Second Quarter 2020 Results”

PSYC (“Global Trac Solutions, Inc.”)Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights

“We are delighted to have established this outstanding partnership with a firm like Microdose who have such a compelling and impressive finger on the pulse of the medicinal psychedelic industry.” LAS VEGAS,- Global Trac Solutions, Inc. (OTCPink: PSYC) is pleased to announce that in an effort to accelerate the Company’s development of premium industry centricContinue reading “PSYC (“Global Trac Solutions, Inc.”)Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights”

Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board

— Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”), is pleased to announce that it has added world renowned drug discovery expert Dr. Denton Hoyer to its Scientific Advisory Board. Dr. Hoyer has been involved in drug discovery at leading pharmaceutical companies and research institutions for the last 30 years. He holdsContinue reading “Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board”